Furthermore, in the MYC-expressing human adult high-grade glioma cell line U305628 we again observed a significant downregulation of CCNB1 after 6 h of BRD4 inhibition via JQ1 (Fig. S7). This evidence concerns the gene BRD4 and central nervous system cancer.